Is Accuray Incorporated (ARAY) overvalued? · rev $458.5M
Accuray Incorporated (ARAY) is a medical devices company listed on US.
This page asks whether Accuray Incorporated (ARAY) looks expensive on cached numbers — not a short thesis.
Latest reported ARAY revenue for 2025-06-30 was $458.5M. Net income was -$1.6M. Revenue was up 2.7% from 2024-06-30 to 2025-06-30. ARAY currently screens at market cap $140.1M.
ARAY currently screens at market cap $140.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ARAY 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ARAY stock page for the full model, not this heading.
Not investment advice.